Over $18M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insider trades were noted in Asana, Inc. (ASAN), Calavo Growers, Inc. (CVGW), and Hepion Pharmaceuticals, Inc. (HEPA). ASAN's CEO acquired 1,015,000 shares at an average price of $18.04, costing around $18.31 million. CVGW's Executive Vice President bought 1,200 shares at an average price of $28.15, costing around $33,776. HEPA's Director purchased 3,000 shares at an average price of $5.61, costing around $16,841.
September 21, 2023 | 8:36 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Asana's CEO acquired 1,015,000 shares, indicating confidence in the company's prospects.
Insider buying, especially by high-ranking officials like the CEO, often indicates confidence in the company's future performance. This could potentially lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Calavo Growers' Executive Vice President bought 1,200 shares, indicating confidence in the company's prospects.
Insider buying, especially by high-ranking officials like the Executive Vice President, often indicates confidence in the company's future performance. This could potentially lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Hepion Pharmaceuticals' Director bought 3,000 shares, indicating confidence in the company's prospects.
Insider buying, especially by high-ranking officials like the Director, often indicates confidence in the company's future performance. This could potentially lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100